NM_001205293.3:c.512+13121T>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001205293.3(CACNA1E):​c.512+13121T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.149 in 152,214 control chromosomes in the GnomAD database, including 2,154 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.15 ( 2154 hom., cov: 32)

Consequence

CACNA1E
NM_001205293.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0130

Publications

4 publications found
Variant links:
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 69
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.206 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ENM_001205293.3 linkc.512+13121T>C intron_variant Intron 3 of 47 ENST00000367573.7 NP_001192222.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1EENST00000367573.7 linkc.512+13121T>C intron_variant Intron 3 of 47 1 NM_001205293.3 ENSP00000356545.2
CACNA1EENST00000360108.7 linkc.512+13121T>C intron_variant Intron 3 of 46 5 ENSP00000353222.3
CACNA1EENST00000367570.6 linkc.512+13121T>C intron_variant Intron 3 of 46 1 ENSP00000356542.1
CACNA1EENST00000621791.4 linkc.512+13121T>C intron_variant Intron 3 of 45 1 ENSP00000481619.1
CACNA1EENST00000524607.6 linkc.947+13121T>C intron_variant Intron 5 of 11 5 ENSP00000432038.2

Frequencies

GnomAD3 genomes
AF:
0.149
AC:
22633
AN:
152096
Hom.:
2150
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0417
Gnomad AMI
AF:
0.192
Gnomad AMR
AF:
0.198
Gnomad ASJ
AF:
0.124
Gnomad EAS
AF:
0.0738
Gnomad SAS
AF:
0.0895
Gnomad FIN
AF:
0.184
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.209
Gnomad OTH
AF:
0.142
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.149
AC:
22646
AN:
152214
Hom.:
2154
Cov.:
32
AF XY:
0.147
AC XY:
10905
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.0417
AC:
1734
AN:
41554
American (AMR)
AF:
0.198
AC:
3023
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.124
AC:
431
AN:
3470
East Asian (EAS)
AF:
0.0743
AC:
386
AN:
5192
South Asian (SAS)
AF:
0.0898
AC:
433
AN:
4822
European-Finnish (FIN)
AF:
0.184
AC:
1948
AN:
10582
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.209
AC:
14205
AN:
67996
Other (OTH)
AF:
0.140
AC:
296
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
983
1966
2949
3932
4915
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
246
492
738
984
1230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.189
Hom.:
1555
Bravo
AF:
0.146
Asia WGS
AF:
0.105
AC:
364
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
7.2
DANN
Benign
0.78
PhyloP100
-0.013
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10910948; hg19: chr1-181493767; API